These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31427479)

  • 1. Diaphragm function does not independently predict exercise intolerance in patients with precapillary pulmonary hypertension after adjustment for right ventricular function.
    Spiesshoefer J; Herkenrath S; Mohr M; Randerath W; Tuleta I; Diller GP; Emdin M; Young P; Henke C; Florian AR; Yilmaz A; Boentert M; Giannoni A
    Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31427479
    [No Abstract]   [Full Text] [Related]  

  • 2. NT-proBNP can be used to detect right ventricular systolic dysfunction in pulmonary hypertension.
    Blyth KG; Groenning BA; Mark PB; Martin TN; Foster JE; Steedman T; Morton JJ; Dargie HJ; Peacock AJ
    Eur Respir J; 2007 Apr; 29(4):737-44. PubMed ID: 17135228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late gadolinium enhancement cardiovascular magnetic resonance predicts clinical worsening in patients with pulmonary hypertension.
    Freed BH; Gomberg-Maitland M; Chandra S; Mor-Avi V; Rich S; Archer SL; Jamison EB; Lang RM; Patel AR
    J Cardiovasc Magn Reson; 2012 Feb; 14(1):11. PubMed ID: 22296860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of NT-proBNP and 6MWD in chronic thromboembolic pulmonary hypertension.
    Suntharalingam J; Goldsmith K; Toshner M; Doughty N; Sheares KK; Hughes R; Jenkins D; Pepke-Zaba J
    Respir Med; 2007 Nov; 101(11):2254-62. PubMed ID: 17706409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PH.
    Kolditz M; Seyfarth HJ; Wilkens H; Ewert R; Bollmann T; Dinter C; Hertel S; Klose H; Opitz C; Grünig E; Höffken G; Halank M
    Lung; 2015 Dec; 193(6):901-10. PubMed ID: 26363916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary vascular and right ventricular reserve in patients with normalized resting hemodynamics after pulmonary endarterectomy.
    Claessen G; La Gerche A; Dymarkowski S; Claus P; Delcroix M; Heidbuchel H
    J Am Heart Assoc; 2015 Mar; 4(3):e001602. PubMed ID: 25801760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-terminal pro-B-type natriuretic peptide as an indicator of disease severity in a heterogeneous group of patients with chronic precapillary pulmonary hypertension.
    Andreassen AK; Wergeland R; Simonsen S; Geiran O; Guevara C; Ueland T
    Am J Cardiol; 2006 Aug; 98(4):525-9. PubMed ID: 16893710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balloon pulmonary angioplasty in patients with inoperable chronic thromboembolic pulmonary hypertension.
    Andreassen AK; Ragnarsson A; Gude E; Geiran O; Andersen R
    Heart; 2013 Oct; 99(19):1415-20. PubMed ID: 23846611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Left atrial volume and N-terminal pro-B type natriuretic peptide are associated with elevated pulmonary artery pressure in patients with systemic sclerosis.
    Dimitroulas T; Giannakoulas G; Papadopoulou K; Sfetsios T; Karvounis H; Dimitroula H; Parcharidou D; Koliakos G; Garyfallos A; Styliadis I; Settas L
    Clin Rheumatol; 2010 Sep; 29(9):957-64. PubMed ID: 20526641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cystatin C: a potential biomarker for pulmonary arterial hypertension.
    Fenster BE; Lasalvia L; Schroeder JD; Smyser J; Silveira LJ; Buckner JK; Brown KK
    Respirology; 2014 May; 19(4):583-9. PubMed ID: 24628703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association of N-terminal pro-brain-type natriuretic peptide with hemodynamics and functional capacity in therapy-naive precapillary pulmonary hypertension: results from a cohort study.
    Berghaus TM; Kutsch J; Faul C; von Scheidt W; Schwaiblmair M
    BMC Pulm Med; 2017 Dec; 17(1):167. PubMed ID: 29202745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Three-dimensional Echocardiography of Right Ventricular Function Correlates with Severity of Pediatric Pulmonary Hypertension.
    Jone PN; Patel SS; Cassidy C; Ivy DD
    Congenit Heart Dis; 2016 Dec; 11(6):562-569. PubMed ID: 26899626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Association between echocardiography derived right ventricular function parameters with cardiac magnetic resonance derived right ventricular ejection fraction and 6-minute walk distance in pulmonary hypertension patients].
    Wang Z; Yang Z; Wan Z; Yu T; Jia L; Du X; Huang C
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Sep; 42(9):748-52. PubMed ID: 25511095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness of scoring right ventricular function for assessment of prognostic factors in patients with chronic thromboembolic pulmonary hypertension.
    Kamimura Y; Okumura N; Adachi S; Shimokata S; Tajima F; Nakano Y; Hirashiki A; Murohara T; Kondo T
    Heart Vessels; 2018 Oct; 33(10):1220-1228. PubMed ID: 29704099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of right ventricular longitudinal strain by 2D speckle tracking imaging compared with RV function and hemodynamics in pulmonary hypertension.
    Li Y; Wang Y; Meng X; Zhu W; Lu X
    Int J Cardiovasc Imaging; 2017 Nov; 33(11):1737-1748. PubMed ID: 28553693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CMR-based heart deformation analysis for quantification of hemodynamics and right ventricular dysfunction in patients with CTEPH.
    Tao X; Liu M; Liu W; Xie W; Wan J; Zhai Z; Wang C
    Clin Respir J; 2020 Mar; 14(3):277-284. PubMed ID: 31814279
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: the UK experience.
    Hoole SP; Coghlan JG; Cannon JE; Taboada D; Toshner M; Sheares K; Fletcher AJ; Martinez G; Ruggiero A; Screaton N; Jenkins D; Pepke-Zaba J
    Open Heart; 2020; 7(1):e001144. PubMed ID: 32180986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive capabilities of a novel cardiovascular magnetic resonance derived marker of cardiopulmonary reserve on established prognostic surrogate markers in patients with pulmonary vascular disease: results of a longitudinal pilot study.
    Baillie TJ; Sidharta S; Steele PM; Worthley SG; Willoughby S; Teo K; Sanders P; Nicholls SJ; Worthley MI
    J Cardiovasc Magn Reson; 2017 Jan; 19(1):3. PubMed ID: 28065166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension.
    Fijalkowska A; Kurzyna M; Torbicki A; Szewczyk G; Florczyk M; Pruszczyk P; Szturmowicz M
    Chest; 2006 May; 129(5):1313-21. PubMed ID: 16685024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Application of cardiopulmonary exercise testing in patients with chronic thromboembolic pulmonary hypertension].
    Zhao ZH; Liu ZH; Gu Q; Luo Q; Zhao Q; Xiong CM; Ni XH
    Zhonghua Yi Xue Za Zhi; 2013 Jun; 93(22):1687-90. PubMed ID: 24124672
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.